Amgen leads with action by investing in industry-leading support and education programs to make sure holistic value is integrated into every medicine.
We support healthcare professionals and patients to make informed decisions about the medicines they choose. That is why Amgen is committed to supporting awareness and education about biologics, including biosimilars, at every level. We facilitate this by providing industry education and partnering with healthcare professionals to foster learning and knowledge sharing.
Amgen also promotes access to all its medicines. We provide comprehensive patient support services with every Amgen medicine and continuously strive to make choosing an Amgen biosimilar an option for patients.
Date of Approval: Dec 2022